Crispr Offers New Hope for Treating Diabetes

Curated from WIRED — Here’s what matters right now:

Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced insulin for months without the patient needing to take immunosuppressants.

Next step: Looking for reliable tools to protect your privacy? Browse our security gear and start building your personal toolkit.

Original reporting: WIRED

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.